McKesson (NYSE: MCK ) is expected to report Q1 earnings on July 25. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict McKesson's revenues will increase 5.7% and EPS will grow 9.7%.
The average estimate for revenue is $32.56 billion. On the bottom line, the average EPS estimate is $1.70.
Last quarter, McKesson logged revenue of $30.62 billion. GAAP reported sales were 3.4% lower than the prior-year quarter's $31.70 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.45. GAAP EPS of $1.09 for Q4 were 48% lower than the prior-year quarter's $2.08 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 6.5%, 70 basis points better than the prior-year quarter. Operating margin was 2.3%, 20 basis points better than the prior-year quarter. Net margin was 0.8%, 80 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $132.81 billion. The average EPS estimate is $8.04.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 621 members out of 646 rating the stock outperform, and 25 members rating it underperform. Among 236 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 229 give McKesson a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on McKesson is outperform, with an average price target of $117.23.
Is McKesson the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add McKesson to My Watchlist.